Botulinum  	Botulinum  	 FW	B-NP
neurotoxin  	neurotoxin  	 FW	I-NP
type  	type  	 FW	I-NP
A-ABO  	A-ABO  	 FW	I-NP
( 	( 	 -LRB-	O
Dysport 	Dysport 	 NNP	B-NP
) 	) 	 -RRB-	O
:  	:  	 :	O
clinical  	clinical  	 JJ	B-NP
indications  	indications  	 NNS	I-NP
and  	and  	 CC	O
practice  	practice  	 NN	B-NP
guide  	guide  	 NN	I-NP
The  	The  	 DT	O
key  	key  	 JJ	B-NP
points  	points  	 NNS	I-NP
to  	to  	 TO	O
remember  	remember  	 VB	O
about  	about  	 IN	O
abobotulinumtoxinA  	abobotulinumtoxinA  	 NNS	B-NP
are  	are  	 VBP	O
as  	as  	 RB	O
follows 	follows 	 VBZ	O
:  	:  	 :	O
BoNTA-ABO  	BoNTA-ABO  	 NNP	B-NP
( 	( 	 -LRB-	O
abobotulinumtoxinA  	abobotulinumtoxinA  	 NNP	B-NP
[ 	[ 	 -LRB-	O
Dysport 	Dysport 	 NNP	B-NP
] 	] 	 -RRB-	O
;  	;  	 :	O
Medicis  	Medicis  	 NNP	B-NP
Aesthetics 	Aesthetics 	 NNP	I-NP
,  	,  	 ,	O
Scottsdale 	Scottsdale 	 NNP	B-NP
,  	,  	 ,	O
AZ 	AZ 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
BoNTA-ONA  	BoNTA-ONA  	 NNP	B-NP
( 	( 	 -LRB-	O
onabotulinumtoxin  	onabotulinumtoxin  	 VB	O
A  	A  	 DT	O
[ 	[ 	 -LRB-	O
Botox  	Botox  	 NNP	B-NP
Cosmetic 	Cosmetic 	 NNP	I-NP
] 	] 	 -RRB-	O
;  	;  	 :	O
Allergan 	Allergan 	 NNP	B-NP
,  	,  	 ,	O
Irvine 	Irvine 	 NNP	O
,  	,  	 ,	O
CA 	CA 	 NNP	B-NP
)  	)  	 -RRB-	O
are  	are  	 VBP	O
both  	both  	 DT	O
derivatives  	derivatives  	 NNS	O
of  	of  	 IN	O
botulinum  	botulinum  	 JJ	B-NP
toxin  	toxin  	 NN	I-NP
A  	A  	 DT	O
produced  	produced  	 VBN	O
from  	from  	 IN	O
different  	different  	 JJ	O
strains  	strains  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
bacterium  	bacterium  	 NN	B-NP
Clostridium  	Clostridium  	 NNP	I-NP
botulinum  	botulinum  	 NN	I-NP
through  	through  	 IN	O
proprietary  	proprietary  	 JJ	B-NP
manufacturing  	manufacturing  	 NN	I-NP
processes 	processes 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
both  	both  	 DT	O
are  	are  	 VBP	O
approved  	approved  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
US  	US  	 NNP	O
Food  	Food  	 NNP	B-NP
and  	and  	 CC	I-NP
Drug  	Drug  	 NNP	I-NP
Administration  	Administration  	 NNP	I-NP
( 	( 	 -LRB-	O
FDA 	FDA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
BoNTA-ABO  	BoNTA-ABO  	 NNP	B-NP
and  	and  	 CC	O
BoNTA-ONA 	BoNTA-ONA 	 JJ	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
are  	are  	 VBP	O
both  	both  	 DT	O
type  	type  	 NN	O
A  	A  	 DT	O
botulinum  	botulinum  	 JJ	B-NP
toxins 	toxins 	 NN	I-NP
,  	,  	 ,	O
should  	should  	 MD	O
be  	be  	 VB	O
further  	further  	 JJ	O
differentiated  	differentiated  	 NN	O
from  	from  	 IN	O
Myobloc  	Myobloc  	 NNP	B-NP
( 	( 	 -LRB-	O
Solstice  	Solstice  	 NNP	B-NP
Neurosciences 	Neurosciences 	 NNP	I-NP
,  	,  	 ,	O
San  	San  	 NNP	O
Francisco 	Francisco 	 NNP	O
,  	,  	 ,	O
CA 	CA 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
the  	the  	 DT	O
only  	only  	 JJ	O
FDA-approved  	FDA-approved  	 JJ	B-NP
type  	type  	 NN	I-NP
B  	B  	 NN	I-NP
botulinum  	botulinum  	 NN	I-NP
toxin 	toxin 	 NN	I-NP
.  	.  	 .	O
BoNTA-ABO 	BoNTA-ABO 	 NNP	B-NP
,  	,  	 ,	O
as  	as  	 RB	O
with  	with  	 IN	O
other  	other  	 JJ	O
derivatives  	derivatives  	 NNS	O
of  	of  	 IN	O
botulinum  	botulinum  	 JJ	B-NP
toxin 	toxin 	 NN	I-NP
,  	,  	 ,	O
produces  	produces  	 VBZ	O
a  	a  	 DT	O
chemodenervation  	chemodenervation  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
muscle  	muscle  	 NN	O
by  	by  	 IN	O
preventing  	preventing  	 VBG	O
the  	the  	 DT	O
release  	release  	 NN	O
and  	and  	 CC	O
binding  	binding  	 JJ	O
of  	of  	 IN	O
acetylcholine  	acetylcholine  	 NN	B-NP
at  	at  	 IN	O
the  	the  	 DT	O
neuromuscular  	neuromuscular  	 JJ	B-NP
endplate 	endplate 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
paralytic  	paralytic  	 JJ	B-NP
effect  	effect  	 NN	I-NP
of  	of  	 IN	I-NP
BoNTA-ABO 	BoNTA-ABO 	 NNP	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
with  	with  	 IN	O
other  	other  	 JJ	O
derivatives  	derivatives  	 NNS	O
of  	of  	 IN	O
botulinum  	botulinum  	 JJ	B-NP
toxin 	toxin 	 NN	I-NP
,  	,  	 ,	O
produces  	produces  	 VBZ	O
a  	a  	 DT	O
relaxation  	relaxation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
underlying  	underlying  	 JJ	O
muscle  	muscle  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
associated  	associated  	 JJ	O
benefit  	benefit  	 NN	O
of  	of  	 IN	O
reducing  	reducing  	 VBG	O
dynamic  	dynamic  	 JJ	B-NP
rhytids  	rhytids  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
overlying  	overlying  	 JJ	O
skin 	skin 	 NN	O
.  	.  	 .	O
BoNTA-ABO  	BoNTA-ABO  	 JJ	B-NP
units  	units  	 NNS	I-NP
are  	are  	 VBP	O
not  	not  	 RB	O
interchangeable  	interchangeable  	 VBN	O
with  	with  	 IN	O
BoNTA-ONA  	BoNTA-ONA  	 JJ	B-NP
units 	units 	 NNS	I-NP
.  	.  	 .	O
An  	An  	 DT	O
understanding  	understanding  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
proper  	proper  	 JJ	O
dosing  	dosing  	 NN	O
and  	and  	 CC	O
familiarity  	familiarity  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
either  	either  	 DT	O
botulinum  	botulinum  	 JJ	B-NP
toxin  	toxin  	 NN	I-NP
in  	in  	 IN	O
aesthetic  	aesthetic  	 JJ	B-NP
applications  	applications  	 NNS	I-NP
is  	is  	 VBZ	O
required  	required  	 VBN	O
to  	to  	 TO	O
produce  	produce  	 VB	O
results  	results  	 NNS	O
that  	that  	 WDT	O
are  	are  	 VBP	O
both  	both  	 DT	O
safe  	safe  	 JJ	O
and  	and  	 CC	O
consistent 	consistent 	 JJ	O
.  	.  	 .	O
Spread  	Spread  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
toxin  	toxin  	 NN	B-NP
is  	is  	 VBZ	O
dependent  	dependent  	 JJ	O
on  	on  	 IN	O
solution  	solution  	 NN	B-NP
volume  	volume  	 NN	I-NP
and  	and  	 CC	O
injection  	injection  	 NN	B-NP
technique  	technique  	 NN	I-NP
( 	( 	 -LRB-	O
physically  	physically  	 RB	O
pushing  	pushing  	 VBG	O
the  	the  	 DT	O
toxin  	toxin  	 NN	B-NP
from  	from  	 IN	O
the  	the  	 DT	O
area  	area  	 NN	O
of  	of  	 IN	O
injection 	injection 	 NN	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Diffusion  	Diffusion  	 NNP	O
of  	of  	 IN	O
the  	the  	 DT	O
toxin  	toxin  	 NN	B-NP
is  	is  	 VBZ	O
largely  	largely  	 RB	O
dependent  	dependent  	 JJ	O
on  	on  	 IN	O
toxin  	toxin  	 NN	O
dose  	dose  	 NN	O
and  	and  	 CC	O
receptor  	receptor  	 JJ	B-NP
concentration 	concentration 	 NN	I-NP
;  	;  	 :	O
unbound  	unbound  	 JJ	O
toxin  	toxin  	 NN	B-NP
moves  	moves  	 NNS	I-NP
down  	down  	 IN	O
a  	a  	 DT	O
concentration  	concentration  	 NN	B-NP
gradient 	gradient 	 NN	I-NP
.  	.  	 .	O
Beyond  	Beyond  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
glabellar  	glabellar  	 JJ	B-NP
rhytids 	rhytids 	 NN	I-NP
,  	,  	 ,	O
there  	there  	 EX	O
are  	are  	 VBP	O
few 	few 	 JJ	O
,  	,  	 ,	O
if  	if  	 IN	O
any 	any 	 DT	O
,  	,  	 ,	O
randomized 	randomized 	 NN	O
,  	,  	 ,	O
double  	double  	 RB	O
blind 	blind 	 JJ	O
,  	,  	 ,	O
placebo-controlled  	placebo-controlled  	 JJ	O
studies  	studies  	 NNS	O
on  	on  	 IN	O
the  	the  	 DT	O
aesthetic  	aesthetic  	 JJ	B-NP
uses  	uses  	 NNS	I-NP
of  	of  	 IN	I-NP
BoNTA-ABO 	BoNTA-ABO 	 JJ	I-NP
.  	.  	 .	O
This  	This  	 DT	O
guide  	guide  	 NN	O
summarizes  	summarizes  	 NNS	O
what  	what  	 WP	O
is  	is  	 VBZ	O
known  	known  	 VBN	O
and  	and  	 CC	O
serves  	serves  	 VBZ	O
as  	as  	 IN	O
a  	a  	 DT	O
basis  	basis  	 NN	O
for  	for  	 IN	O
clinical  	clinical  	 JJ	B-NP
use  	use  	 NN	I-NP
and  	and  	 CC	O
continued  	continued  	 JJ	O
understanding 	understanding 	 NN	O
.  	.  	 .	O
